David Perry & Associates
Sep. 23rd, 2010
On the heels of a successful first year of promoting business exchange between China and San Francisco, ChinaSF (www.sfced.org/international/chinasf) has named Ginny Fang as its new Executive Director. Fang’s new role and the organization’s growth will be marked by a reception on Wednesday, September 29 featuring remarks and insights from Dr. Keyong Ren, M.D., Ph.D. Chief Investment Director Healthcare Fund for the China Construction Bank International (CCBI). Ren, who is visiting from Bejing and has recently joined the Advisory Board for ChinaSF, will be speaking on “Trends in Chinese Investment into the US Biotech and Life Sciences Industry.”
Disclaimer
This article is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. It is not intended to be, and should not be construed as, investment advice. Prospective investors should consult with their own financial, legal, and tax advisors before making any investment decision.
The information is based on current laws and regulations, which are subject to change. The company does not undertake any obligation to update this information to reflect changes in laws, regulations, or market conditions. Readers should be aware that such changes may affect the accuracy of the information provided.
The views and opinions expressed are those of the authors and do not necessarily reflect the official policy or position of the company or its affiliates. Statements regarding market trends or future events are based on the authors' analysis and should not be construed as factual assertions.
This article complies with SEC marketing guidelines and USCIS regional center rules. The company has made reasonable efforts to ensure accuracy but does not guarantee completeness and disclaims liability for any errors or omissions.
The article may contain forward-looking statements based on current expectations and assumptions. These statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially due to various factors, including changes in economic and market conditions.